{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/diarrhoea-antibiotic-associated/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"14b5fd2c-0a9a-58b3-af3b-54e8f6c587a3","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 10adc49d-7d7f-46d4-8e15-e4e160a6b940 --><h2>Changes</h2><!-- end field 10adc49d-7d7f-46d4-8e15-e4e160a6b940 -->","summary":null,"htmlStringContent":"<!-- begin item d2c4e2bd-1d94-4c1f-a170-a38cfe484543 --><!-- begin field da97949a-e4d7-42b0-89f3-9978f9e07c14 --><p><strong>November 2020 </strong>— minor update. Broken URL link updated.</p><p><strong>February to March 2019 </strong>— reviewed. A literature search was conducted in January 2019 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. There are no major changes to the recommendations in this topic.</p><!-- end field da97949a-e4d7-42b0-89f3-9978f9e07c14 --><!-- end item d2c4e2bd-1d94-4c1f-a170-a38cfe484543 -->","topic":{"id":"e3d5d597-cb8d-5009-95be-96d5f61f622c","topicId":"60505e59-3d44-4100-ba77-670b2dda81a3","topicName":"Diarrhoea - antibiotic associated","slug":"diarrhoea-antibiotic-associated","lastRevised":"Last revised in November 2020","chapters":[{"id":"ff00d31e-fff0-5539-893c-63eaae28aa91","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d4f02cb1-a605-5763-85b8-7e30efe0b52d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b4be21a4-fea2-52ee-99b9-6ad9b7f42b37","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"14b5fd2c-0a9a-58b3-af3b-54e8f6c587a3","slug":"changes","fullItemName":"Changes"},{"id":"86cd74d6-6f35-5de4-9031-55397958409b","slug":"update","fullItemName":"Update"}]},{"id":"d9b8d789-d6e6-5a0f-80ef-2853843c67b6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"93a9787b-a3ca-5bd2-9dd1-e7bd5ebd7e61","slug":"goals","fullItemName":"Goals"},{"id":"712c6134-ba14-5e2a-987b-8d3c06033ee0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"04b62294-302f-5852-90f5-60c1f9593a96","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"98b4954c-4b96-5b7a-9888-99cfd0b2ce3d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7f04cf05-c2de-5fb3-9f58-b7e32b7a8604","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d849aa0f-051e-5e61-8d05-6da99fdc60e0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"146be3ba-ef2c-5d7c-a6be-75d743b6cbdb","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3deeffef-b60e-557b-a9ce-2ca055de0653","slug":"definition","fullItemName":"Definition"},{"id":"788d8348-35a0-5147-b765-a90a068257b9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7804f825-6a78-5c22-89f7-9ecb4f2ac588","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"4d2b177e-1c5d-5783-b256-b0b7173e4660","slug":"complications","fullItemName":"Complications"},{"id":"0d3b3c20-ff70-5653-9cb1-750667c15098","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"db6311c9-b63f-5037-89f3-fe2ed41761c7","fullItemName":"Management","slug":"management","subChapters":[{"id":"1ddecd55-2bf4-53db-8594-8c1489126404","slug":"diarrhoea-antibiotic-associated","fullItemName":"Scenario: Diarrhoea - antibiotic associated"}]},{"id":"e0650ec6-ca9b-5cf0-9761-2ffe00571666","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4f209e3e-56a5-5f47-859e-8b6f0b9b9fe9","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"1a19af07-ea9e-59ac-8ce6-508d4d01e536","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ecd4dd69-cf4c-507f-9659-b23f2a5b3272","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b0079d2b-b8c1-59e3-a1c1-f6f2c83a07c5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"919502d7-1740-58a4-8ea5-2feeb47d6e28","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d1844305-0beb-50de-a2de-fbea6a58b880","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"766c971f-c448-56d3-a9d4-2ffded846f90","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7d18a1e0-eeb3-5b2f-bd26-e9f231d83c40","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"99309640-cab2-57c4-8bd0-2c05065abd69","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b4be21a4-fea2-52ee-99b9-6ad9b7f42b37","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"ff05b079-cd45-5708-9de5-a168d72e0497","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 76f0dbcf-65a5-46ed-b966-4a79bbcc8cf0 --><h3>Previous changes</h3><!-- end field 76f0dbcf-65a5-46ed-b966-4a79bbcc8cf0 -->","summary":null,"htmlStringContent":"<!-- begin item 409f18b9-bd11-4879-93e1-5f8d64de7d52 --><!-- begin field 04aa39dd-427d-44b5-9a6d-60ee98f6f8e6 --><p><strong>October 2018 </strong>— minor update. Adverse effects updated within prescribing information - metronidazole. </p><p><strong>March 2018 </strong>—<strong> </strong>minor update. Advice on the use of probiotics as an adjunct to the management of <em>Clostridium difficile - </em>associated diarrhoea was added. </p><p><strong>March to June 2013 </strong>— reviewed. A literature search was conducted in February 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. There are no major changes to the recommendations in this topic.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>May 2011 </strong>— minor update. Recommendations from the Department of Health letter, <em>Diagnostic testing for Clostridium difficile </em>infection, have been included in this topic. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>July to September 2009 </strong>— this is a new CKS topic. Together with the updated CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-prevention-advice-for-travellers/\">Diarrhoea - prevention and advice for travellers</a> and <a class=\"topic-reference external-reference\" href=\"/topics/gastroenteritis/\">Gastroenteritis</a>, this CKS topic replaces the former topic on <em>Gastroenteritis</em>.</p><p><strong>November 2008 </strong>— minor update to the text to amend advice regarding the assessment and investigation of pregnant women with gastroenteritis. Issued in December 2008.</p><p><strong>July to September 2006 </strong>— reviewed. Validated in December 2006 and issued in January 2007.</p><p><strong>July 2007 </strong>— minor update to the text to include advice regarding the assessment and investigation of pregnant women with gastroenteritis.</p><p><strong>January 2006 </strong>— minor update. Nalidixic acid tablets discontinued and prescriptions have been removed. Issued in February 2006.</p><p><strong>June 2003 </strong>— reviewed. Validated in September 2003 and issued in October 2003.</p><p><strong>January 2000 </strong>— rewritten. Validated in March 2000 and issued in May 2000.</p><p><strong>October 1998 </strong>— written.</p><!-- end field 04aa39dd-427d-44b5-9a6d-60ee98f6f8e6 --><!-- end item 409f18b9-bd11-4879-93e1-5f8d64de7d52 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}